IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

KCK Ltd.

Q4 2024 Holdings

Filed 2025-01-15 | 3 holdings | $75.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Neuropace Inc(NPCE)COM641288105$59.0M5,270,84578.7%
Sight Sciences Inc(SGHT)COM82657M105$15.9M4,374,97521.2%
Aileron Therapeutics Inc(RNTX)COM NEW00887A204$51.4K22,3410.1%